Rajendra Patel v iNova Pharmaceuticals (Singapore) Pte

In the matter of *Rajendra Patel v iNova Pharmaceuticals (Singapore) Pte*, heard before Jock McDonagh, the dispute concerned the validity of certain trade marks. The evidence presented included declarations detailing the history of Valeant as a global pharmaceutical company and the acquisition of the "iNova Marks" by Valeant. These marks were originally owned by 3M, then transferred to iNova Pharmaceuticals (Australia) Pty Ltd in 2006, subsequently acquired by Valeant in 2011, assigned to the Opponent on 29 September 2017, and ultimately owned by iNova Pharmaceuticals (Singapore) Pte.

The central legal issue before the court was to determine the relevant time at which the grounds of opposition must be established. The court was required to consider whether this point in time was the Priority Date, as suggested by established legal precedent.

The court applied the principle that the time at which grounds of opposition must be established is the Priority Date. This principle was supported by reference to *Southern Cross Refrigerating v Toowoomba Foundry Pty Ltd* (1953) 91 CLR 592, 595, which affirmed that the relevant date for assessing opposition grounds is the Priority Date. The court's reasoning focused on the established legal framework for trade mark oppositions, emphasizing the importance of the Priority Date in determining the validity of such claims.